RxDoctor Payments Data

Jonathan Pillow, MD

Otolaryngology · Edmond, OKNPI 1861531139

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 46.2% of the total. Reporting peaked in 2024 at $523 and has fallen 57.2% since, to $224 in 2025.

$1,861in general payments, 2019–2025

Across 67 payments — averaging $27.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$860
  • Sanofi$319
  • Sanofi-aventis U.S. LLC$155
  • Optinose US, Inc.$134
  • Alk-abello, Inc$130
  • Paratek Pharmaceuticals, Inc.$116
  • plus $148 from 5 others

What the payments were for

  • Food & beverage$1,80897%
  • Education$533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,861 in reported general payments places this provider in the 60th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$90,841
Medicare patients
488
Services billed
2,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Montelukast Sodium83$1,492
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,114
Ipratropium Bromide28$884
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$623
Fluticasone Propionate32$609
Omeprazole50$485
Azelastine Hcl16$479
Doxycycline Hyclate21$261
Fluconazole11$150
Ondansetron OdtOndansetron13$81
Levofloxacin15$72
Prednisone34$55
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$41

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →